Giulio G. Muccioli

Giulio Muccioli (born in 1978) He is recognized as a world expert in endocannabinoid receptors. His research is focused on the roles of bioactive lipids both in physiological and pathological situations, mainly related to inflammation.

Education

Giulio Muccioli studied pharmacy at the University of Louvain. After that, he completed from 2005 to 2007 a Post-Doctoral Fellowship in the laboratory of Prof. Nephi Stella at the University of Washington (Seattle, USA), specialized in Cannabinoid Pharmacology

Career

Giulio Muccioli returned to the University of Louvain, first as an F.R.S.-FNRS Research Fellow (2007–2008). Since 2008 he has been Professor in the Faculty of Pharmacy and Biomedical Sciences.

He created a research group, the Bioanalysis and Pharmacology of Bioactive Lipids (BPBL), within the Louvain Drug Research Institute (LDRI), which he currently leads. His research interests encompass the roles of bioactive lipids both in physiological mechanisms and pathological situations, mainly related to inflammation and related diseases, such as obesity, multiple sclerosis, inflammatory bowel disease or cancer. and vice president of the Louvain Drug Research Institute.

In 2018, Giulio Muccioli became with the BPBL research group co-organizer of the European Workshop on Lipid Mediators.

Awards

In 2016, Giulio Muccioli received a research award from the Belgian Charcot Foundation for his project to study the effect of NAAA inhibition on the course of experimental autoimmune encephalitis in mice.

In 2018, Giulio Muccioli won the Eugène De Somer Award for upstanding work in fundamental research in the biomedical sciences field.